Plasma human immunodeficiency virus type 1 (HIV-1) turnover and kinetics were studied in children aged 15 days to 2 years following the initiation of a triple antiretroviral drug regimen consisting of zidovudine, lamivudine, and nevirapine. HIV-1 turnover was at least as rapid as that previously described in adults; turnover rates were more rapid in infants and children aged 3 months to 2 years than in infants less than 3 months of age. These data confirm the central role of HIV-1 replication in the pathogenesis of vertical HIV-1 infection and reinforce the importance of early, potent combination therapies for the long-term control of HIV-1 replication
BackgroundEarly initiation of combination antiretroviral therapy (cART) to human immunodeficiency vi...
OBJECTIVES: Identification of HIV infection in exposed infants facilitates early therapy, which may ...
In a series of 97 infants born to mothers who were seropositive for human immunodeficiency virus typ...
Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate t...
About one-third of vertically HIV-1 infected infants develop AIDS within the first months of life; t...
About one-third of vertically HIV-1 infected infants develop AIDS within the first months of life; t...
BACKGROUND: Early initiation of combination antiretroviral therapy (cART) to human immunodeficiency ...
The primary aim of this study was to measure HIV-1 persistence following combination antiretroviral ...
The primary aim of this study was to measure HIV-1 persistence following combination antiretroviral ...
BACKGROUND: Human immunodeficiency virus (HIV) infection in infancy features a persistently high vir...
OBJECTIVE:Determine the decay rate of HIV-1 DNA reservoir in vertically infected children during sus...
BACKGROUND: The decay of human immunodeficiency virus type 1 (HIV-1)-infected cells during early com...
The effectiveness and tolerance of antiretroviral therapy with a combination of three reverse transc...
Initiation of combined antiretroviral therapy within the first 12 weeks of life in vertically human ...
BACKGROUND: Early HIV diagnosis allows combination antiretroviral therapy (cART) initiation in the f...
BackgroundEarly initiation of combination antiretroviral therapy (cART) to human immunodeficiency vi...
OBJECTIVES: Identification of HIV infection in exposed infants facilitates early therapy, which may ...
In a series of 97 infants born to mothers who were seropositive for human immunodeficiency virus typ...
Studies of potent antiretroviral combination regimens were undertaken in young infants to evaluate t...
About one-third of vertically HIV-1 infected infants develop AIDS within the first months of life; t...
About one-third of vertically HIV-1 infected infants develop AIDS within the first months of life; t...
BACKGROUND: Early initiation of combination antiretroviral therapy (cART) to human immunodeficiency ...
The primary aim of this study was to measure HIV-1 persistence following combination antiretroviral ...
The primary aim of this study was to measure HIV-1 persistence following combination antiretroviral ...
BACKGROUND: Human immunodeficiency virus (HIV) infection in infancy features a persistently high vir...
OBJECTIVE:Determine the decay rate of HIV-1 DNA reservoir in vertically infected children during sus...
BACKGROUND: The decay of human immunodeficiency virus type 1 (HIV-1)-infected cells during early com...
The effectiveness and tolerance of antiretroviral therapy with a combination of three reverse transc...
Initiation of combined antiretroviral therapy within the first 12 weeks of life in vertically human ...
BACKGROUND: Early HIV diagnosis allows combination antiretroviral therapy (cART) initiation in the f...
BackgroundEarly initiation of combination antiretroviral therapy (cART) to human immunodeficiency vi...
OBJECTIVES: Identification of HIV infection in exposed infants facilitates early therapy, which may ...
In a series of 97 infants born to mothers who were seropositive for human immunodeficiency virus typ...